Envelope variation as a primary determinant of lentiviral vaccine efficacy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 38, 2007, Pages 15105-15110

  Craigo, Jodi K ^a   Zhang, Baoshan ^a   Barnes, Shannon ^a   Tagmyer, Tara L ^a   Cook, Sheila J ^b   Issel, Charles J ^b   Montelaro, Ronald C ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Ancestral immunogen; Equine infectious anemia virus; Lentivirus

Indexed keywords

GLYCOPROTEIN GP 90; LENTIVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANTIGENIC VARIATION; ARTICLE; CORRELATION ANALYSIS; DRUG EFFICACY; ENVELOPE GENE; HORSE DISEASE; HUMAN; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRAL S2 ACCESSORY GENE; VIRUS ENVELOPE; VIRUS GENE; VIRUS MUTATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; EQUINE INFECTIOUS ANEMIA; FEMALE; GENE PRODUCTS, ENV; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; LENTIVIRUSES, EQUINE; MALE; TIME FACTORS; VIRAL PROTEINS; VIRAL VACCINES; VIRULENCE;

ANIMALIA; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS;

EID: 35448980321     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0706449104     Document Type: Article

References (52)

1. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, Novitsky V, Haynes B, Hahn BH, Bhattacharya T, Korber B (2002) Science 296:2354-2360.
2. Anastassopoulou CG, Kostrikis LG (2006) Curr HIV Res 4:365-373.
3. Brander C, Frahm N, Walker BD (2006) Curr Opin Immunol 18:430-437.
4. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V (2001) Br Med Bull 58:19-42.
5. Mullins JI, Jensen MA (2006) Curr Top Microbiol Immunol 299:171-192.
6. Jones NA, Wei X, Flower DR, Wong M, Michor F, Saag MS, Hahn BH, Nowak MA, Shaw GM, Borrow P (2004) J Exp Med 200:1243-1256.
7. Lue J, Hsu M, Yang D, Marx P, Chen Z, Cheng-Mayer C (2002) J Virol 76:10299-10306.
8. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, et al. (2003) Nature 422:307-312.
9. O'Connor DH, Allen TM, Watkins DI (2002) DNA Cell Biol 21:659-664.
10. Kusumi K, Conway B, Cunningham S, Berson A, Evans C, Iversen AK, Colvin D, Gallo MV, Coutre S, Shpaer EG (1992) J Virol 66:875-885.
11. O'Connor D, Friedrich T, Hughes A, Allen TM, Watkins D (2001) Immunol Rev 183:115-126.
12. Rong R, Gnanakaran S, Decker JM, Bibollet-Ruche F, Taylor J, Sfakianos JN, Mokili JL, Muldoon M, Mulenga J, Allen S, et al. (2007) J Virol 81:5658-5668.
13. Howe L, Craigo JK, Issel CJ, Montelaro RC (2005) J Gen Virol 86:139-149.
14. Howe L, Leroux C, Issel CJ, Montelaro RC (2002) J Virol 76:10588.
15. Kinsey NE, Anderson MG, Unangst TJ, Joag SV, Narayan O, Zink MC, Clements JE (1996) Virology 221:14-21.
16. Johnson WE, Lifson JD, Lang SM, Johnson RP, Desrosiers RC (2003) J Virol 77:375-381.
17. Dey B, Pancera M, Svehla K, Shu Y, Xiang, S-H., Vainshtein J, Li Y, Sodroski J, Kwong PD, Mascola JR, Wyatt R (2007) J Virol 81:5579-5593.
18. Brander C, Self S, Korber B (2007) Curr Opin in HIV AIDS 2:183-188.
19. Montelaro RC, Ball JM, Rushlow K, Levy JA (1993) in The Retroviridae (Plenum, New York), Vol 2, pp 257-360.
20. Harrold SM, Cook SJ, Cook RF, Rushlow KE, Issel CJ, Montelaro RC (2000) J Virol 74:3112-3121.
21. Hammond SA, Li F, McKeon BM, Sr, Cook SJ, Issel CJ, Montelaro RC (2000) J Virol 74:5968-5981.
22. Kono Y, Hirasawa K, Fukunaga Y, Taniguchi T (1976) Nat Inst Anim Health Quart 16:8-15.
23. Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC (2007) Vaccine 25:834-845.
24. Craigo JK, Li F, Steckbeck JD, Durkin S, Howe L, Cook SJ, Issel C, Montelaro RC (2005) J Virol 79:2666-2677.
25. Li F, Craigo JK, Howe L, Steckbeck JD, Cook S, Issel C, Montelaro RC (2003) J Virol 77:7244-7253.
26. Montelaro RC, Wigzell H (1995) AIDS 9(Suppl A):S111-S112.
27. Mills J, Desrosiers RC, Rud E, Almond N (2000) AIDS Res Hum Retroviruses 16:1453-1461.
28. Leroux C, Craigo JK, Issel CJ, Montelaro RC (2001) J Virol 75:4570-4583.
29. Craigo JK, Sturgeon TJ, Cook SJ, Issel CJ, Leroux C, Montelaro RC (2006) Virology 344:340-353.
30. Hammond SA, Cook SJ, Lichtenstein DL, Issel CJ, Montelaro RC (1997) J Virol 71:3840-3852.
31. Li F, Puffer BA, Montelaro RC (1998) J Virol 72:8344-8348.
32. Leroux C, Issel C, Montelaro RC (1997) J Virol 71:9627-9639.
33. Cook RF, Cook SJ, Berger SL, Leroux C, Ghabrial NN, Gantz M, Bolin PS, Mousel MR, Montelaro RC, Issel CJ (2003) Virology 313:588-603.
34. Lichtenstein DL, Issel CJ, Montelaro RC (1996) J Virol 70:3346-3354.
35. Issel CJ, Horohov DW, Lea DF, Adams WV, Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC (1992) J Virol 66:3398-3408.
36. Montelaro RC, Cole KS, Hammond SA (1998) AIDS Res Hum Retroviruses 14(Suppl 3):S255-S259.
37. Craigo JK, Leroux C, Howe L, Steckbeck JD, Cook SJ, Issel CJ, Montelaro RC (2002) J Gen Virol 83:1353-1359.
38. Bogers WM, Cheng-Mayer C, Montelaro RC (2000) AIDS 14:S141-S145.
39. Johnson RP (1999) Nat Med 5:154-155.
40. Johnson RP, Desrosiers RC (1998) Curr Opin Immunol 10:436-443.
41. Blower SM, Koelle K, Kirschner DE, Mills J (2001) Proc Natl Acad Sci USA 98:3618-3623.
42. Almond N, Stott J (1999) Immunol Lett 66:167-170.
43. Shen RX, Wang Z (1985) in EIAV: A National Review of Policies, Programs, and Future Objectives (American Quarterhorse Association, Amarillo, TX).
44. Johnson RP, Lifson JD, Czajak SC, Cole KS, Manson KH, Glickman R, Yang J, Montefiori DC, Montelaro R, Wyand MS, Desrosiers RC (1999) J Virol 73:4952-4961.
45. Kumar A, Mukherjee S, Shen J, Buch S, Li Z, Adany I, Liu Z, Zhuge W, Piatak M, Lifson JD, et al. (2002) Virology 301:189-205.
46. Amara RR, Patel K, Niedziela G, Nigam P, Sharma S, Staprans SI, Montefiori DC, Chenareddi L, Herndon JG, Robinson HL, et al. (2005) J Virol 79:15356-15367.
47. Busch M, Abel K, Li J, Piatak M, Jr, Lifson JD, Miller CJ (2005) Vaccine 23:4036-4047.
48. Abel K, Compton L, Rourke T, Montefiori D, Lu D, Rothaeusler K, Fritts L, Bost K, Miller CJ (2003) J Virol 77:3099-3118.
49. Nickle DC, Jensen MA, Gottlieb GS, Shriner D, Learn GH, Rodrigo AG, Mullins JI (2003) Science 299:1515-1518 and author reply, pp 1515-1518.
50. Grund CH, Lechman ER, Issel CJ, Montelaro RC, Rushlow KE (1994) J Gen Virol 75(Pt 3):657-662.
51. Cook RF, Cook SJ, Li FL, Montelaro RC, Issel CJ (2002) J Virol Methods 105:171-179.
52. Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC (2007) J Gen Virol 88:1324-1336.